Cargando…

Risk Factors for Recurrent Pedatric Community Associated Clostridium difficile Infection

BACKGROUND: As rates of pediatric community-associated (CA) Clostridium difficile infection (CDI) increase, additional research is needed to address the paucity of data in this cohort. Studies in pediatrics suggest concurrent antibiotics, CA CDI, malignancy, recent surgery, the number of antibiotic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parmar, Deepika, Dang, Rebecca, Katz, Margot Miranda, Alabaster, Amy, Greenhow, Tara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631086/ http://dx.doi.org/10.1093/ofid/ofx163.1813

Ejemplares similares

Incidence of Pediatric Community Associated Clostridium Difficile Infection Following Common Antibotics
por: Katz, Margot Miranda, et al.
Publicado: (2017)

Risk Factors for Community-Associated Clostridium difficile Infection in Children
por: Weng, Mark, et al.
Publicado: (2017)

283 Antimicrobial Susceptibility Trends in Staphylococcus aureus isolated from Pedatric Patients in Military Treatment Facilities
por: Chukwuma, Uzo, et al.
Publicado: (2014)

Lyophilized Fecal Microbiota Transplantation Capsules for Recurrent Clostridium difficile Infection
por: Dupont, Hebert, et al.
Publicado: (2017)

525 Epidemiology and burden of recurrent Clostridium difficile infections
por: Sheitoyan-Pesant, Caroline, et al.
Publicado: (2014)

Comparison of Fidaxomicin and Vancomycin for Recurrent Clostridium difficile Colitis
por: Khoo, Teresa, et al.
Publicado: (2017)

1660 Risk of Recurrent Clostridium difficile Infection: Impact of Diagnostics and Treatment
por: Reddy, Sujan C., et al.
Publicado: (2014)

71 Alterations in the Gut Microbiome in Recurrent Clostridium difficile Infection
por: Wang, Gary, et al.
Publicado: (2014)

Socioeconomic Status Factors Associated with Increased Incidence of Community-Associated Clostridium difficile Infection
por: Skrobarcek, Kimberly, et al.
Publicado: (2017)

507. Degree of Concordance of Clostridium difficile Strains in Adults with Community-Associated C. difficile Infection and Infants With C. difficile Colonization
por: Clayton, Jason A, et al.
Publicado: (2018)

1501. Risk Factors for Clostridium difficile Infection in Patients Hospitalized with Community-Acquired Pneumonia
por: Deshpande, Abhishek, et al.
Publicado: (2019)

Engraftment and Augmentation of Microbiome Following Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection
por: Lee, Christine, et al.
Publicado: (2017)

502. Enhanced Sporulation and Vancomycin Resistance Associated With Clostridium difficile From Recurrent Infections
por: Tijerina-Rodriguez, Laura E, et al.
Publicado: (2018)

1644 Risk Factors for Community-Associated Clostridium difficile Infection in Children
por: Crews, Jonathan, et al.
Publicado: (2014)

The Impact of Diagnostic Stewardship on Clostridium difficile Infections
por: Bischoff, Werner, et al.
Publicado: (2017)

Endogenous Serum IgG Antibodies to Clostridium difficile Toxin B Are Associated with Protection against C. difficile Infection Recurrence
por: Kelly, Ciaran P, et al.
Publicado: (2017)

Tea and Recurrent Clostridium difficile Infection
por: Oman Evans II, Martin, et al.
Publicado: (2016)

469. Validation and Characterization of Community-Acquired Clostridium difficile Infections from the Quebec C. difficile Infection Surveillance Program (QCISP)
por: Kazadi-Lukusa, Aimé, et al.
Publicado: (2018)

519. Longer Length of Antibiotic Therapy for Community-Acquired Pneumonia and Risk of Clostridium difficile Infection
por: Yi, Sarah H, et al.
Publicado: (2018)

External validation of predictive scores for mortality following Clostridium difficile infection
por: Beauregard-Paultre, Catherine, et al.
Publicado: (2017)

External validation of clinical scores to predict complications of Clostridium difficile infection
por: Beauregard-Paultre, Catherine, et al.
Publicado: (2017)

Cost Effectiveness Analysis of Fecal Transplant Delivery Methods for Recurrent Clostridium difficile Infections in Outpatients
por: Walker, Jeremey, et al.
Publicado: (2017)

2407. Overexpression of Virulence Factors in Biofilm from Recurrent Clostridium (Clostridioides) difficile Infection Isolates.
por: Tijerina, Laura, et al.
Publicado: (2019)

Etiology of Infectious Diarrhea in Patients Tested for Clostridium difficile: If It Isn’t Clostridium difficile, What Is It?
por: Kwon, Jennie H, et al.
Publicado: (2017)

492. Long-Term Outcomes of Clostridium difficile Infection Among Medicare Beneficiaries
por: Hatfield, Kelly M, et al.
Publicado: (2018)

517. Impact of Doxycycline in Place of Azithromycin for Community-Acquired Pneumonia on Clostridium difficile Infections
por: John, Jamie, et al.
Publicado: (2018)

2168. Regional Variation in Community-Onset and Hospital-Identified Clostridium difficile Infection, 2017
por: Van Santen, Katharina, et al.
Publicado: (2018)

975. Clostridium difficile Infection and Antibiotic Prescription Rates in the Community: Explaining the Gender Gap
por: Younas, Mariam, et al.
Publicado: (2018)

1641 Evaluation of Co-Infections among Patients with Community-Associated Clostridium difficile Infection
por: Cohen, Jessica, et al.
Publicado: (2014)

Feces transplantation for recurrent Clostridium difficile infection: US experience and recommendations
por: Bakken, Johan S.
Publicado: (2015)

Risk Factors for Delayed Recurrence of Clostridium difficile Infection
por: Kim, Ji Won
Publicado: (2014)

Risk Factors Associated With Recurrent Clostridium difficile Infection
por: Dharbhamulla, Nikhita, et al.
Publicado: (2019)

Predictors of 30-day All-cause Mortality in Veterans with First Recurrence of Clostridium difficile Infection (CDI)
por: Morrill, Haley, et al.
Publicado: (2017)

500. Efficacy of 30-Day Fidaxomicin for Treatment of Acute Clostridium difficile Infection With History of Multiple Recurrences
por: Lee, Christine, et al.
Publicado: (2018)

1122. Evaluation of Fecal Microbiota Transplant (FMT) in Elderly Patients With recurrent Clostridium difficile Infection (CDI)
por: Hassoun, Ali, et al.
Publicado: (2018)

2673. Risk Factors for Clostridium difficile Infection in Lung Transplant Patients
por: DeRose, Joseph L, et al.
Publicado: (2019)

467. Investigation of a Clostridium difficile Infection (CDI) Outbreak in a Community Teaching Hospital
por: Parker, Laura, et al.
Publicado: (2018)

Effectiveness of FMT in recurrent Clostridium difficile infection
por: Grzesiowski, P, et al.
Publicado: (2015)

Hypoalbuminemia as predictor of recurrence of Clostridium difficile infection
por: Knafl, Daniela, et al.
Publicado: (2019)

Updates in Treatment of Recurrent Clostridium difficile Infection
por: Singh, Tanveer, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_s4lsqvmi3ou4enjq1galg8900c